Scinai Immunotherapeutics Ltd. , a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases, and other illnesses in Israel.
Scinai Immunotherapeutics stock last closed at $0.45, down 4.66% from the previous day, and has decreased 75.68% in one year. It has underperformed other stocks in the Biotechnology industry by 0.52 percentage points. Scinai Immunotherapeutics stock is currently +4.41% from its 52-week low of $0.43, and -80.18% from its 52-week high of $2.27.
At the moment, there are 1.45B shares of SCNI outstanding. The market cap of SCNI is $1.96M. In the last 24 hours, 5585 SCNI shares were traded.
You will need an online brokerage account to access the NASDAQ market and buy SCNI stock.
We believe that eToro is the best brokerage. eToro gives you:
Get $10 towards your share purchase by opening an account with eToro today.
Open eToro AccountNow that you've chosen the best brokerage, the next step is to fill out some personal information so you are able to invest in SCNI today.
Now that you have created your account on the best beginner stock app, you can securely and quickly fund your account:
Watch this video walkthrough for more details depositing funds into your investment account.
Once you have figured out the best place to buy Scinai Immunotherapeutics stock, it's absolutely critical to analyze their stock prior to buying, so you truly understand the risk as well as the upside.
WallStreetZen was built to help average investors do more accurate fundamental analysis in less time.
You can see all of the due diligence checks on SCNI's stock page.
You can use many financial metrics, analyses, models, and charts to gauge SCNI's true value.
You can do additional valuation research on SCNI's stock here.
You can dig deeper into what analysts are projecting on the Scinai Immunotherapeutics stock forecast page.
Over the last 12 months, insiders at SCNI have not bought or sold any shares.
Dig into more about who owns SCNI shares here.
No, Scinai Immunotherapeutics doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
You have two main order types:
Click the Open button and eToro will place your order.
If you require additional help with investing in stocks on eToro, watch the helpful video below:
Now that you own some SCNI shares, you'll want to stay up-to-date on your new shares.
Put SCNI on a watchlist to track the most important metrics related to your SCNI stock.
To reiterate, here are the 6 steps to buy Scinai Immunotherapeutics stock:
If you need a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to keep an eye on your new investment in Scinai Immunotherapeutics, get started below.